Kassidy Nelson, OD | |
631 Lincoln Ave, Wamego, KS 66547-1635 | |
(785) 456-2236 | |
Not Available |
Full Name | Kassidy Nelson |
---|---|
Gender | Female |
Speciality | Optometry |
Experience | 5 Years |
Location | 631 Lincoln Ave, Wamego, Kansas |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1023670932 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
152W00000X | Optometrist | 2104 (Kansas) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Ryan J. Kueker, Od, Pa | 7810922390 | 3 |
News Archive
New research suggests that use of antibiotics is still prevalent among terminal patients who have chosen hospice care as an end-of-life option, despite little evidence that the medications improve symptoms or quality of life, and sometimes may cause unwanted side effects.
Cancer drugs of the new, molecular generation destroy malignant breast tumors in a targeted manner: They block characteristic molecules on tumor cells - receptors for the hormones estrogen or progesterone, or a co-receptor, called HER2, that binds to many growth factors. But about one in every six breast tumors has none of these receptors. Such cancers, called triple-negative, are particularly aggressive and notoriously difficult to treat.
Genes that affect the immune system and link it to Parkinson's disease have been uncovered. This paves the way for new drug development in Parkinson's disease – a serious, degenerative disease of the nerves that leads to tremors and muscle stiffness and eventually complete loss of movements. There is currently no cure for PD.
Abbott (NYSE: ABT) today announced financial results for the third quarter ended Sept. 30, 2009.
› Verified 4 days ago
Provider Name | Ryan J. Kueker, Od, Pa |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1033201876 PECOS PAC ID: 7810922390 Enrollment ID: O20051004000313 |
News Archive
New research suggests that use of antibiotics is still prevalent among terminal patients who have chosen hospice care as an end-of-life option, despite little evidence that the medications improve symptoms or quality of life, and sometimes may cause unwanted side effects.
Cancer drugs of the new, molecular generation destroy malignant breast tumors in a targeted manner: They block characteristic molecules on tumor cells - receptors for the hormones estrogen or progesterone, or a co-receptor, called HER2, that binds to many growth factors. But about one in every six breast tumors has none of these receptors. Such cancers, called triple-negative, are particularly aggressive and notoriously difficult to treat.
Genes that affect the immune system and link it to Parkinson's disease have been uncovered. This paves the way for new drug development in Parkinson's disease – a serious, degenerative disease of the nerves that leads to tremors and muscle stiffness and eventually complete loss of movements. There is currently no cure for PD.
Abbott (NYSE: ABT) today announced financial results for the third quarter ended Sept. 30, 2009.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Kassidy Nelson, OD 631 Lincoln Ave, Wamego, KS 66547-1635 Ph: (785) 456-2236 | Kassidy Nelson, OD 631 Lincoln Ave, Wamego, KS 66547-1635 Ph: (785) 456-2236 |
News Archive
New research suggests that use of antibiotics is still prevalent among terminal patients who have chosen hospice care as an end-of-life option, despite little evidence that the medications improve symptoms or quality of life, and sometimes may cause unwanted side effects.
Cancer drugs of the new, molecular generation destroy malignant breast tumors in a targeted manner: They block characteristic molecules on tumor cells - receptors for the hormones estrogen or progesterone, or a co-receptor, called HER2, that binds to many growth factors. But about one in every six breast tumors has none of these receptors. Such cancers, called triple-negative, are particularly aggressive and notoriously difficult to treat.
Genes that affect the immune system and link it to Parkinson's disease have been uncovered. This paves the way for new drug development in Parkinson's disease – a serious, degenerative disease of the nerves that leads to tremors and muscle stiffness and eventually complete loss of movements. There is currently no cure for PD.
Abbott (NYSE: ABT) today announced financial results for the third quarter ended Sept. 30, 2009.
› Verified 4 days ago
Ryan J. Kueker, Od, Pa Optometrist Medicare: Medicare Enrolled Practice Location: 631 Lincoln St, Wamego, KS 66547 Phone: 785-456-2236 Fax: 785-456-2570 | |
Dr. Troy Michael Juenemann, OD Optometrist Medicare: Medicare Enrolled Practice Location: 631 Lincoln Ave, Wamego, KS 66547 Phone: 785-845-6223 | |
Dr. Ryan Jennings Kueker I, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 631 Lincoln St, Wamego, KS 66547 Phone: 785-456-2236 Fax: 785-456-2570 | |
Vision Source Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1405 W Us Highway 24, Wamego, KS 66547 Phone: 785-456-8900 Fax: 785-456-8902 | |
Kyler Knobbe, Od, Llc Optometrist Medicare: Medicare Enrolled Practice Location: 1405 W Us Highway 24, Wamego, KS 66547 Phone: 785-456-8900 Fax: 785-456-8902 | |
Dr. Nicole J Wainwright, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 631 Lincoln Ave, Wamego, KS 66547 Phone: 785-456-2236 Fax: 785-456-2570 |